omniture
logo
Search
Samsung Biologics Co. Ltd.
Media Room

Latest News

rss

Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

INCHEON, South Korea, Sept. 22, 2021 /PRNewswire/ -- Samsung Biologics, a global contract developme...

2021-09-22 18:00 2212
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

INCHEON, South Korea, Sept. 13, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world'...

2021-09-13 12:41 2506
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

* Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12....

2021-07-20 20:00 2206
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

Samsung Biologics Issues Its First Annual Sustainability Report

* Consolidation of the company's roadmap to creating an improved business environment * Establi...

2021-06-25 09:01 23320
Samsung Biologics Issues Its First Annual Sustainability Report

Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

* Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessm...

2021-06-23 19:28 1946
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

INCHEON, South Korea, June 2, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's ...

2021-06-02 19:00 2266
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

* Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its...

2021-05-31 19:00 3130
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

* Expanding upon its existing ISO22301 certification, Samsung Biologics is now fully certified wi...

2021-05-28 20:00 3567
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management
1234